4//SEC Filing
DRW Holdings, LLC 4
Accession 0001193805-21-001123
CIK 0000882361other
Filed
Aug 4, 8:00 PM ET
Accepted
Aug 5, 9:54 PM ET
Size
16.7 KB
Accession
0001193805-21-001123
Insider Transaction Report
Form 4
DRW Commodities, LLC
10% Owner
Transactions
- Sale
Common Stock
2021-08-05$2.62/sh−60,000$157,200→ 8,888,275 total(indirect: By LLC) - Purchase
Common Stock
2021-08-03$2.65/sh+57,199$151,406→ 8,948,275 total(indirect: By LLC)
Holdings
- 4,162(indirect: By LLC)
Common Stock
DRW Holdings, LLC
10% Owner
Transactions
- Purchase
Common Stock
2021-08-03$2.65/sh+57,199$151,406→ 8,948,275 total(indirect: By LLC) - Sale
Common Stock
2021-08-05$2.62/sh−60,000$157,200→ 8,888,275 total(indirect: By LLC)
Holdings
- 4,162(indirect: By LLC)
Common Stock
Wilson Donald R. Jr.
10% Owner
Transactions
- Purchase
Common Stock
2021-08-03$2.65/sh+57,199$151,406→ 8,948,275 total(indirect: By LLC) - Sale
Common Stock
2021-08-05$2.62/sh−60,000$157,200→ 8,888,275 total(indirect: By LLC)
Holdings
- 4,162(indirect: By LLC)
Common Stock
Footnotes (3)
- [F1]The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.64 to $2.65, inclusive. The Reporting Persons (as defined below) undertake to provide to Aptose Biosciences Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F2]This Form 4 is being filed by the undersigned Donald R. Wilson Jr. ("Wilson"), as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the "Reporting Persons"). Wilson is the sole manager of each of DRW Investments, LLC ("DRW Investments"), DRW Commodities, LLC ("DRW Commodities") and DRW Holdings, LLC ("DRW Holdings"). DRW Holdings owns 100% of the outstanding equity of each of DRW Commodities and DRW Investments. A majority of the equity of DRW Holdings is owned, directly or indirectly, by trusts for the benefit of members of Wilson's immediate family and of which Wilson serves as trustee or investment advisor.
- [F3]Each of the Reporting Persons disclaims beneficial ownership of any securities held by DRW Commodities or DRW Investments, except to the extent of his indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise.
Documents
Issuer
Aptose Biosciences Inc.
CIK 0000882361
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001535383
Filing Metadata
- Form type
- 4
- Filed
- Aug 4, 8:00 PM ET
- Accepted
- Aug 5, 9:54 PM ET
- Size
- 16.7 KB